LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    The world’s first plant for the production of 1,4 bio-butanediol from renewable resources

    18/09/2024

    CASE STUDY

    Submission from Assobiotec

    The innovation.

    1,4, Butanediol is a chemical intermediate used for a wide range of applications, including industrial processes (as a solvent) and the manufacture of diverse products including textiles, electronics, automotive and consumer goods as used in the biopolymer sector. Traditionally produced through chemical processes, the development of a biotechnology-derived process now enables its production with a 50% reduction in greenhouse gas emissions. This is a significant shift towards biotechnology within the production of bioplastics and biochemicals.

    In 2016, the world’s first industrial scale plant was developed which integrated a biorefinery into existing chemical processes to produce 1,4 BDO directly from sugars, enabling the significant reduction in greenhouses gases from biotechnology-driven process. The plant can produce up to 30,000 tons per year and is a starting point for further integration of feedstock supplies (raw materials for fuel or production) for manufacturing.

    The benefits.

    The use of biobutanediol allows the reduction of the net Global Warming Potential “Cradle to gate” by 50% in terms of CO2 equivalent emissions, compared to the fossil alternative. The delta has been determined as the difference between the carbon footprint profile of 1,4 bio-BDO (ISO 14067:2018 certified) and the carbon footprints of fossil BDO available in literature, reflecting the most representative process technology.

    Moreover, the plant is designed to reuse by-products for its own energy purpose, optimizing the whole life-cycle process. In 2020, the anaerobic digester started the first biogas production from industrial waste consisting of thermally inactivated bacteria and their residues. By introducing an additional treatment system, the biogas is now converted into biomethane and fed into the national network, allowing to further increase the plant’s efficiency.

     

    Additional materials:

    Mater-Biotech: The development of innovative industrial biotechnology processes complete our integrated biorefineries in local area

    The world's first plant for the production of 1,4 bio-butanediol from renewable resources


    Download

    Share
    Communications Team
    Communications Team

    Related posts

    29/01/2026

    EuropaBio Consultation Response: Public Procurement Directives


    Read more
    23/01/2026

    Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.


    Read more
    22/01/2026

    BIOTECH AUSTRIA joins EuropaBio: Fostering Austrian Biotech Collaboration


    Read more

    Important links

    • EuropaBio Consultation Response: Public Procurement Directives
    • Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.